243 related articles for article (PubMed ID: 28902718)
1. Effect of drug-coated balloon on stent restenosis, neointimal proliferation, and coronary dissection: an optical coherence tomography analysis.
Fukushima T; Ashikaga T; Yoshikawa S; Hatano Y; Ueshima D; Yamamoto T; Yasuhiro M; Isobe M
Coron Artery Dis; 2018 Jan; 29(1):39-45. PubMed ID: 28902718
[TBL] [Abstract][Full Text] [Related]
2. Neointimal tissue healing patterns after paclitaxel-eluting balloon treatment of in-stent restenosis: optical coherence tomography and intravascular ultrasound insights.
Sandoval J; Medina M; Alfonso F
J Invasive Cardiol; 2012 Oct; 24(10):E215-8. PubMed ID: 23043046
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
4. Differences in optical coherence tomographic findings and clinical outcomes between excimer laser and cutting balloon angioplasty for focal in-stent restenosis lesions.
Nishino M; Lee Y; Nakamura D; Yoshimura T; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
J Invasive Cardiol; 2012 Oct; 24(10):478-83. PubMed ID: 23043029
[TBL] [Abstract][Full Text] [Related]
5. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
6. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
[TBL] [Abstract][Full Text] [Related]
7. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
8. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
[TBL] [Abstract][Full Text] [Related]
9. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty.
Tada T; Kadota K; Hosogi S; Miyake K; Amano H; Nakamura M; Izawa Y; Kubo S; Ichinohe T; Hyoudou Y; Eguchi H; Hayakawa Y; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Tanaka H; Fuku Y; Kato H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):307-15. PubMed ID: 24042176
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW
EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329
[TBL] [Abstract][Full Text] [Related]
11. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
[TBL] [Abstract][Full Text] [Related]
12. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
14. Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.
Liistro F; Porto I; Angioli P; Grotti S; Ducci K; Falsini G; Bolognese L
Am Heart J; 2013 Nov; 166(5):920-6. PubMed ID: 24176449
[TBL] [Abstract][Full Text] [Related]
15. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study.
Unverdorben M; Vallbracht C; Cremers B; Heuer H; Hengstenberg C; Maikowski C; Werner GS; Antoni D; Kleber FX; Bocksch W; Leschke M; Ackermann H; Boxberger M; Speck U; Degenhardt R; Scheller B
EuroIntervention; 2015 Dec; 11(8):926-34. PubMed ID: 25169589
[TBL] [Abstract][Full Text] [Related]
17. Different Neointimal Pattern in Early vs. Late In-Stent Restenosis and Clinical Outcomes After Drug-Coated Balloon Angioplasty - An Optical Coherence Tomography Study.
Lee JH; Jung HW; Kim JS; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
Circ J; 2018 Oct; 82(11):2745-2752. PubMed ID: 30197402
[TBL] [Abstract][Full Text] [Related]
18. Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.
Miyazaki T; Ashikaga T; Fukushima T; Hatano Y; Sasaoka T; Kurihara K; Ono Y; Shimizu S; Otomo K; Hirao K
J Interv Cardiol; 2019; 2019():6515129. PubMed ID: 31772538
[TBL] [Abstract][Full Text] [Related]
19. Serial Observations of In-Stent Restenosis Treated With Drug-Coated Balloon Angioplasty by Optical Coherence Tomography and Coronary Angioscopy.
Murata N; Takayama T; Hiro T
Int Heart J; 2017 Feb; 58(1):134-139. PubMed ID: 28111411
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease.
Nishiyama N; Komatsu T; Kuroyanagi T; Fujikake A; Komatsu S; Nakamura H; Yamada K; Nakahara S; Kobayashi S; Taguchi I
Int J Cardiol; 2016 Nov; 222():113-118. PubMed ID: 27494722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
